Novo Nordisk sues rival Eli Lilly over weight loss drug advertising
First publishedJul 21, 18:40 UTC
Last updatedJul 22, 18:35 UTC · 19m ago
1 outlet
The Hill
1 outlets over time — hover a bar for its window & outletslast updated
Answer
Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its weight loss drugs. The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound lead to significantly more weight loss than Novo Nordisk’s Ozempic and...
Reported by 1 outlet — The Hill. See all sources ↓
Read the full report at The Hill ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its weight loss drugs. The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound lead to significantly more weight loss than Novo Nordisk’s Ozempic and...
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 19m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Novo Nordisk sues rival Eli Lilly over weight loss drug advertising
Sources1TypeCoverage
Related in the knowledge graph
organizationDrugmaker Novo NordiskorganizationEli LillyorganizationLillyorganizationMounjaroorganizationNew JerseyorganizationNovo NordiskorganizationOzempicorganizationZepbound
Sources (1)
Avg source rating 7.0/10Processing cluster
A1A2A3B1B2B3